Cargando…
Denosumab-induced hypocalcemia in a patient with hyperthyroidism: a case report
Denosumab is a humanized monoclonal antibody targeting the receptor activator of nuclear factor kappa-B ligand (RANKL). Denosumab is an effective treatment for osteoporosis but can cause hypocalcemia. We present a case of denosumab-induced hypocalcemia in a patient with hyperthyroidism with a high b...
Autores principales: | Park, S.Y., Kim, J., Chung, H.Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758617/ https://www.ncbi.nlm.nih.gov/pubmed/34232341 http://dx.doi.org/10.1007/s00198-021-06059-2 |
Ejemplares similares
-
Denosumab-induced hypocalcemia post bariatric surgery—a severe and protracted course: a case report
por: Awang, Mohd Hazriq, et al.
Publicado: (2023) -
Severe Hypocalcemia due to Denosumab in Metastatic Prostate Cancer
por: Muqeet Adnan, Mohammed, et al.
Publicado: (2014) -
Denosumab-Induced Hypocalcemia after Billroth II Gastric Bypass Surgery
por: Schmucker, Abigail M., et al.
Publicado: (2020) -
Severe hypocalcemia after denosumab administration in a patient with chronic kidney disease: a case report
por: Kouroglou, Eleni, et al.
Publicado: (2023) -
The Calcium Culprit: A Case of Denosumab-induced Hypocalcemia
por: Kalayanamitra, Ricci, et al.
Publicado: (2019)